Remove 2025 Remove Leads Remove Networking
article thumbnail

PatientPoint Unveils New Interactive Solution to Streamline Care Team Communication

PM360

First of its kind, in-office, digital hub enhances provider efficiency and care team collaboration Cincinnati, Ohio – October 7, 2024 – PatientPoint® a leading digital health company, today showcased the transformation of its healthcare professional solution with the launch of an interactive, in-office digital hub.

article thumbnail

5 Proven Social Media Marketing Strategies for Pharma Brands

Pharma Marketing Network

By understanding your audience, balancing content, engaging transparently, using influencers, and continuously analyzing performance, your social media strategy will be primed for success in 2025. What are the top platforms for pharma marketing in 2025? LinkedIn and Twitter are leading platforms for professional and medical content.

Media 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Beyond transparent pricing: decoding the strategies of major PBMs

Clarivate

Express Scripts ClearNetwork (effective from early 2024) Cost-plus pricing model; includes ESI’s 65,000-plus site retail pharmacy network; prescription pricing is based on the lowest of three benchmarks: NADAC, WAC or PAC; Pharmacies receive a flat dispensing fee plus up to 15% markup.

Retail 59
article thumbnail

MedTechVets at the 2024 MedTech Conference in Toronto

MedTechVets

Marc Chauvette spoke candidly about the unexpected difficulties of the job search: “We learned so many things in the military, but basic life skills—like networking—were not part of that training. Networking is essential in civilian life, and many veterans don’t fully realize that until they dive into programs like MedTechVets.”

article thumbnail

Making ATMPs a reality for rare disease patients

European Pharmaceutical Review

Starting in 2025, health technology assessment (HTA) experts from across Europe will join forces to produce joint clinical assessment (JCA) reports, which will be used to support national health economic assessments as well as inform pricing and reimbursement discussions. Internet] European Commission. cited2023Oct]. cited 2023Oct].

article thumbnail

Bristol Myers Squibb aims to improve disability diversity in clinical trials

European Pharmaceutical Review

The DDiCT project will be co-led by Bristol Myers Squibb (BMS)’s Disability Advancement Workplace Network (DAWN) and the Global Drug Development Team. Therefore, it is essential that we broaden the scope of medical trials and research,” commented Tinamarie Duff, DAWN Global People & Business Resource Group Lead.

article thumbnail

The U.S. health insurance market is undergoing a post-pandemic sea change

Clarivate

After staying relatively flat for several years, enrollment growth took off in 2021 after an expansion in federal subsidies for silver-level plans passed in the American Rescue Plan and was then renewed through 2025 in the Inflation Reduction Act. Pillo, Senior Healthcare Research and Data Analyst. The post The U.S.